Millennium Management’s West Pharmaceutical WST Stock Holding History

Millennium Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,300	Closed	-$941K	–	6522
2025 Q2	$941K	Sell	4,300 -27,100	-86%	-$5.79M	﹤0.01%	4453
2025 Q1	$7.03M	Buy	+31,400	New	+$8.65M	﹤0.01%	2527
2024 Q4	–	Sell	-4,500	Closed	-$1.35M	–	6524
2024 Q3	$1.35M	Sell	4,500 -9,300	-67%	-$2.85M	﹤0.01%	4030
2024 Q2	$4.55M	Buy	+13,800	New	+$4.88M	﹤0.01%	2811
2023 Q4	–	Sell	-10,000	Closed	-$3.75M	–	6611
2023 Q3	$3.75M	Buy	10,000 +5,000	+100%	+$1.93M	﹤0.01%	2986
2023 Q2	$1.91M	Buy	5,000 +2,000	+67%	+$714K	﹤0.01%	3516
2023 Q1	$1.04M	Buy	+3,000	New	+$877K	﹤0.01%	4061
2018 Q4	–	Sell	-100,000	Closed	-$12.3M	–	4234
2018 Q3	$12.3M	Buy	+100,000	New	+$11.2M	0.02%	1159

Other funds holding WST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management's WST Position: Q1 2026 in Review

Millennium Management reduced its West Pharmaceutical (WST) stake by 88% in Q1 2026, selling an estimated $24M and leaving 13,775 shares worth $3.45M. The position accounts for ﹤0.01% of the portfolio, ranked #3339.

Millennium Management first reported a position in WST in Q4 2013 and has held it in 45 quarters since. The position peaked at $204M in Q1 2024. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

Millennium Management held 13,775 shares of West Pharmaceutical worth $3.45M as of Q1 2026.
Millennium Management sold 96,618 West Pharmaceutical shares in Q1 2026, an estimated $24M.
West Pharmaceutical made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3339 holding.
Millennium Management first reported a position in West Pharmaceutical in Q4 2013 and has held it in 45 quarters since.
Millennium Management's West Pharmaceutical position peaked at $204M in Q1 2024.
753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.